Cytoki Pharma is a startup based in Denmark, 1 tracked investor.
Based in Denmark, Cytoki Pharma is a startup. Brouky records 1 investor associated with the company.
Cytoki Pharma is a biotechnology company developing protein therapeutics for diseases characterized by epithelial injury, with a focus on a licensed long-acting IL-22 program for inflammatory bowel disease. The company also has a clinical program (CK-0045) in Phase 2 for obesity and type 2 diabetes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.